{"disease":{"id":"nucleophosmin-1-mutated-acute-myeloid-leukemia","name":"nucleophosmin 1 mutated acute myeloid leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05020665","title":"Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Kronos Bio","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}